• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌标本和细胞系中CXCR5表达的临床及生物学意义。

Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.

作者信息

Singh Shailesh, Singh Rajesh, Singh Udai P, Rai Shesh N, Novakovic Kristian R, Chung Leland W K, Didier Peter J, Grizzle William E, Lillard James W

机构信息

Department of Microbiology and Immunology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.

出版信息

Int J Cancer. 2009 Nov 15;125(10):2288-95. doi: 10.1002/ijc.24574.

DOI:10.1002/ijc.24574
PMID:19610059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3600527/
Abstract

Chemokines and chemokine receptors have been shown to be involved in metastatic process of prostate cancer (PCa). In this study, we show primary PCa tissues and cell lines (LNCaP and PC3) express CXCR5, a specific chemokine receptor for CXCL13. Expression of CXCR5 was significantly higher (p < 0.001) in PCa cases than compared to normal match (NM) tissues. CXCR5 intensity correlated (R(2) = 0.97) with Gleason score. While prostate tumor tissues with Gleason scores >or= 7, displayed predominantly nuclear CXCR5 expression patterns, PCa specimens with Gleason scores <or= 6 showed predominantly membrane and cytoplasmic expression patterns that were comparable to benign prostatic hyperplasia (BPH). Similar to tissue expression, PCa cell lines expressed significantly more CXCR5 than normal prostatic epithelial cells (PrECs), and CXCR5 expression was distributed among intracellular and extracellular compartments. Functional in vitro assays showed higher migratory and invasive potentials toward CXCL13, an effect that was mediated by CXCR5. In both PCa cell lines, CXCL13 treatment increased the expression of collagenase-1 or matrix metalloproteinase-1 (MMP-1), collagenase-3 (MMP-13), stromelysin-1 (MMP-3), stromelysin-2 (MMP-10) and stromelysin-3 (MMP-11). These data demonstrate the clinical and biological relevance of the CXCL13-CXCR5 pathway and its role in PCa cell invasion and migration.

摘要

趋化因子和趋化因子受体已被证明参与前列腺癌(PCa)的转移过程。在本研究中,我们发现原发性PCa组织和细胞系(LNCaP和PC3)表达CXCR5,即CXCL13的特异性趋化因子受体。与正常对照(NM)组织相比,PCa病例中CXCR5的表达显著更高(p < 0.001)。CXCR5强度与Gleason评分相关(R(2) = 0.97)。Gleason评分≥7的前列腺肿瘤组织主要显示核CXCR5表达模式,而Gleason评分≤6的PCa标本主要显示与良性前列腺增生(BPH)相当的膜和细胞质表达模式。与组织表达相似,PCa细胞系表达的CXCR5明显多于正常前列腺上皮细胞(PrECs),且CXCR5表达分布于细胞内和细胞外区室。体外功能试验显示,对CXCL13具有更高迁移和侵袭潜能,这一效应由CXCR5介导。在两种PCa细胞系中,CXCL13处理均增加了胶原酶-1或基质金属蛋白酶-1(MMP-1)、胶原酶-3(MMP-13)、基质溶解素-1(MMP-3)、基质溶解素-2(MMP-10)和基质溶解素-3(MMP-11)的表达。这些数据证明了CXCL-13-CXCR5途径的临床和生物学相关性及其在PCa细胞侵袭和迁移中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/2d26069205bd/nihms137666f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/0abc26d49434/nihms137666f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/249cb45d7145/nihms137666f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/b732ebf8a821/nihms137666f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/df238cbf6736/nihms137666f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/b081f4b11699/nihms137666f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/2d26069205bd/nihms137666f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/0abc26d49434/nihms137666f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/249cb45d7145/nihms137666f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/b732ebf8a821/nihms137666f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/df238cbf6736/nihms137666f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/b081f4b11699/nihms137666f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f09f/3600527/2d26069205bd/nihms137666f6.jpg

相似文献

1
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.前列腺癌标本和细胞系中CXCR5表达的临床及生物学意义。
Int J Cancer. 2009 Nov 15;125(10):2288-95. doi: 10.1002/ijc.24574.
2
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.血清CXCL13与前列腺疾病、前列腺特异性抗原呈正相关,并介导前列腺癌细胞侵袭、整合素聚集和细胞黏附。
Cancer Lett. 2009 Sep 28;283(1):29-35. doi: 10.1016/j.canlet.2009.03.022. Epub 2009 Apr 17.
3
PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.PI3Kp110-、Src-、FAK 依赖性和 DOCK2 非依赖性 CXCL13 刺激的前列腺癌细胞的迁移和侵袭。
Mol Cancer. 2010 Apr 22;9:85. doi: 10.1186/1476-4598-9-85.
4
Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5.前列腺癌细胞中不同G蛋白亚基的表达及其与CXCR5的相互作用
Mol Cancer. 2013 Jun 18;12:64. doi: 10.1186/1476-4598-12-64.
5
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.CCR9在前列腺癌细胞迁移和侵袭中的表达及功能作用
Clin Cancer Res. 2004 Dec 15;10(24):8743-50. doi: 10.1158/1078-0432.CCR-04-0266.
6
Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.转录组网络分析鉴定前列腺肿瘤免疫微环境中的 CXCL13-CXCR5 信号模块。
Sci Rep. 2019 Oct 18;9(1):14963. doi: 10.1038/s41598-019-46491-3.
7
The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.炎性趋化因子受体CXCR5在良性前列腺增生和前列腺癌中的差异表达及功能
Int J Med Sci. 2015 Oct 15;12(11):853-61. doi: 10.7150/ijms.11713. eCollection 2015.
8
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.趋化因子CXCL13在乳腺癌患者的肿瘤组织和外周血中过度表达。
Br J Cancer. 2008 Sep 16;99(6):930-8. doi: 10.1038/sj.bjc.6604621.
9
Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 () in Hyperplastic Prostate.C-X-C 基序趋化因子配体 13() 在前列腺增生中的表达和功能活性变化。
Int J Mol Sci. 2022 Dec 21;24(1):56. doi: 10.3390/ijms24010056.
10
CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.CXCL13 通过 JNK 信号转导介导前列腺癌细胞增殖,并通过 ERK 激活介导侵袭。
Cell Prolif. 2011 Aug;44(4):311-9. doi: 10.1111/j.1365-2184.2011.00757.x. Epub 2011 Jun 6.

引用本文的文献

1
Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression.外泌体非编码RNA及其调控网络在肝癌进展中的综合分析
Pract Lab Med. 2025 Mar 21;45:e00464. doi: 10.1016/j.plabm.2025.e00464. eCollection 2025 Jul.
2
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.趋化因子 CXCL13 是多发性骨髓瘤溶骨性微环境、M2 巨噬细胞极化和肿瘤进展的新角色。
J Hematol Oncol. 2022 Oct 10;15(1):144. doi: 10.1186/s13045-022-01366-5.
3
Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment.

本文引用的文献

1
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer.CXC趋化因子mRNA表达作为前列腺癌的一种潜在诊断工具
Mol Med Rep. 2008 Mar-Apr;1(2):257-62.
2
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.血清CXCL13与前列腺疾病、前列腺特异性抗原呈正相关,并介导前列腺癌细胞侵袭、整合素聚集和细胞黏附。
Cancer Lett. 2009 Sep 28;283(1):29-35. doi: 10.1016/j.canlet.2009.03.022. Epub 2009 Apr 17.
3
Cancer statistics, 2008.
CXCL13-CXCR5轴在肿瘤微环境中的调节作用。
Precis Clin Med. 2018 Jun;1(1):49-56. doi: 10.1093/pcmedi/pby006. Epub 2018 Jun 12.
4
A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.B 细胞还是关键角色?B 细胞和抗体在黑色素瘤中的不同作用。
Pigment Cell Melanoma Res. 2022 May;35(3):303-319. doi: 10.1111/pcmr.13031. Epub 2022 Mar 4.
5
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.趋化因子与细胞因子:前列腺癌发病机制中的轴心与同盟
Semin Cancer Biol. 2022 Nov;86(Pt 3):497-512. doi: 10.1016/j.semcancer.2022.02.017. Epub 2022 Feb 16.
6
CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.CXCL13在癌症及其他疾病中的作用:生物学功能、临床意义及治疗前景
Life (Basel). 2021 Nov 23;11(12):1282. doi: 10.3390/life11121282.
7
CXCL13 Signaling in the Tumor Microenvironment.CXCL13 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1302:71-90. doi: 10.1007/978-3-030-62658-7_6.
8
CXCR5 induces perineural invasion of salivary adenoid cystic carcinoma by inhibiting microRNA-187.CXCR5 通过抑制 microRNA-187 诱导唾液腺腺样囊性癌的神经周围侵犯。
Aging (Albany NY). 2021 Jun 10;13(11):15384-15399. doi: 10.18632/aging.203097.
9
Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.《护士健康研究中循环炎症生物标志物与卵巢癌风险》
Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):710-718. doi: 10.1158/1055-9965.EPI-20-1390. Epub 2021 Feb 9.
10
Mini-review: Trophic interactions between cancer cells and primary afferent neurons.综述:癌细胞与初级传入神经元之间的营养相互作用。
Neurosci Lett. 2021 Feb 16;746:135658. doi: 10.1016/j.neulet.2021.135658. Epub 2021 Jan 19.
2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
4
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.CXCR7/RDC1作为CXCL12/SDF-1的趋化因子受体在前列腺癌中的作用。
J Biol Chem. 2008 Feb 15;283(7):4283-94. doi: 10.1074/jbc.M707465200. Epub 2007 Dec 5.
5
Correlation between the in vitro ATP-based chemosensitivity assay and HER2/neu expression in women with breast cancer.基于ATP的体外化学敏感性检测与乳腺癌女性患者HER2/neu表达之间的相关性
J Int Med Res. 2007 Nov-Dec;35(6):753-61. doi: 10.1177/147323000703500603.
6
CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow.趋化因子受体5(CXCR5)可能参与人类转移性神经母细胞瘤细胞向骨髓的迁移过程。
Cancer Immunol Immunother. 2008 Apr;57(4):541-8. doi: 10.1007/s00262-007-0392-2. Epub 2007 Sep 5.
7
The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.CXCR5趋化因子受体由癌细胞表达,并促进结肠癌在肝脏中的生长。
Cancer Res. 2006 Oct 1;66(19):9576-82. doi: 10.1158/0008-5472.CAN-06-1507.
8
Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.前列腺肿瘤CXC趋化因子谱与细胞对内皮和细胞外基质的黏附相关。
Life Sci. 2006 Mar 13;78(16):1784-93. doi: 10.1016/j.lfs.2005.08.019. Epub 2005 Nov 2.
9
Expression of CCL5 (RANTES) and CCR5 in prostate cancer.CCL5(调节激活正常T细胞表达和分泌因子)和CCR5在前列腺癌中的表达
Prostate. 2006 Feb 1;66(2):124-34. doi: 10.1002/pros.20306.
10
Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression.趋化因子受体CCR7在伴有全身淋巴结病的前列腺癌中的表达:病例报告、文献综述及趋化因子受体表达分析
Urol Oncol. 2005 Jul-Aug;23(4):261-7. doi: 10.1016/j.urolonc.2005.02.004.